ARTICLE | Company News
Dynavax submits Heplisav MAA
July 25, 2012 1:52 AM UTC
Dynavax Technologies Corp. (NASDAQ:DVAX) submitted an MAA to EMA for Heplisav to prevent HBV infection caused by all known subtypes in adults ages 18-70 years and in patients with chronic kidney disea...